Sanofi-aventis U.s. Llc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Sanofi-aventis U.s. Llc
Patents: | 4 |
Tradenames: | 10 |
Ingredients: | 9 |
BLAs: | 10 |
Biologic Drugs for Sanofi-aventis U.s. Llc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | See Plans and Pricing | |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | 5,370,629 | See Plans and Pricing |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | 5,509,905 | See Plans and Pricing |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | 5,656,722 | See Plans and Pricing |
Sanofi-aventis U.s. Llc | APIDRA | insulin glulisine | Injection | 021629 | 2004-04-16 | See Plans and Pricing | |
Sanofi-aventis U.s. Llc | APIDRA | insulin glulisine | Injection | 021629 | 2004-04-16 | 6,221,633 | See Plans and Pricing |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
This search can help find similar names.